Wordt geladen...
Oncogenic miR-9 is a target of erlotinib in NSCLCs
EGFR-targeted cancer therapy is a breakthrough in non-small cell carcinoma. miRNAs have been proved to play important roles in cancer. Currently, for the role of miRNAs in EGFR-targeted cancer therapy is unclear. In this study, first we found that erlotinib reduced the expression of miR-9. MiR-9 exp...
Bewaard in:
| Gepubliceerd in: | Sci Rep |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4655475/ https://ncbi.nlm.nih.gov/pubmed/26593208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17031 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|